Lv3
370 积分 2025-06-02 加入
Long-term outcomes of atezolizumab–bevacizumab in unresectable hepatocellular carcinoma: A real-world study
15小时前
待确认
Disparities in stage at diagnosis for liver cancer in China
17小时前
已完结
Predictors of survival in patients with advanced hepatocellular carcinoma who permanently discontinued sorafenib
21小时前
已完结
From TCR fundamental research to innovative chimeric antigen receptor design
3天前
已完结
Association of proteinuria with improved prognosis in unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab, and the predictive role of serum vascular endothelial growth factor D levels: A multicenter retrospective study
5天前
已完结
Sequencing of systemic therapy in unresectable hepatocellular carcinoma: A systematic review and Bayesian network meta-analysis of randomized clinical trials
8天前
已完结
Combination therapy strategies targeting glypican-3 in hepatocellular carcinoma: A comprehensive review
1个月前
已完结
Progression-free survival, disease-free survival and other composite end points in oncology: improved reporting is needed
1个月前
已完结
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
2个月前
已完结
The changing landscape of cancer cell therapies: clinical trials and real-world data
2个月前
已完结
皖公网安备34019202002308
